Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer.
about
Role of angiogenesis in urothelial bladder carcinomaPlatelet-derived growth factor receptor beta: a novel urinary biomarker for recurrence of non-muscle-invasive bladder cancer.Chemoprevention of urothelial cell carcinoma growth and invasion by the dual COX-LOX inhibitor licofelone in UPII-SV40T transgenic miceLoss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinomaAlternative splicing of VEGFA, APP and NUMB genes in colorectal cancerPrognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy.Glucocorticoid receptor beta increases migration of human bladder cancer cellsThe impact of cyclin D1 overexpression on the prognosis of bladder cancer: a meta-analysis.Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity.The effects of alternative splicing on miRNA binding sites in bladder cancer.A critical review on ramucirumab in the treatment of advanced urothelial cancer.A Phase II Trial of Dovitinib in BCG-Unresponsive Urothelial Carcinoma with FGFR3 Mutations or Overexpression: Hoosier Cancer Research Network Trial HCRN 12-157.VEGFA isoforms play a vital role in oral cancer progression.
P2860
Q28080330-82DD28A3-E110-4C69-BCBF-B5A2FE52E035Q33573393-A7FFD2A2-B31C-4813-AD40-D069833614E7Q35027361-C75522EA-9BE2-4650-8A5B-06337FEFE0AFQ35063395-C363AD83-B260-4EC8-972D-692F0710893BQ35692268-04F3C685-E34F-4EE5-B5EB-102E05382547Q36953563-63804DB8-9C0F-4311-B6A6-1B556127E9E3Q37317245-440C5DD5-6498-483F-9EE3-23854CBA0168Q37681535-DB34F194-EDC7-4A3C-8B11-DD82F3F198FFQ38307997-3D1067A0-2168-4E12-93E6-F9AAF42C0022Q47232846-359F0ECC-690F-4E46-A322-0565B915F696Q47787312-45F76455-25FA-4EB1-ABDE-10D7BB3E8FC2Q52815341-A134013A-0495-4FBD-BD16-E9B9E113072FQ53571593-75D78BEC-094D-4FA7-9ABE-EB4C9BEE3347
P2860
Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Expression analysis of VEGF-A ...... parameters in bladder cancer.
@en
Expression analysis of VEGF-A ...... parameters in bladder cancer.
@nl
type
label
Expression analysis of VEGF-A ...... parameters in bladder cancer.
@en
Expression analysis of VEGF-A ...... parameters in bladder cancer.
@nl
prefLabel
Expression analysis of VEGF-A ...... parameters in bladder cancer.
@en
Expression analysis of VEGF-A ...... parameters in bladder cancer.
@nl
P2093
P356
P1433
P1476
Expression analysis of VEGF-A ...... l parameters in bladder cancer
@en
P2093
Anne Clairotte
Eric Chabannes
Guillaume Boiteux
Hugues Bittard
Isabelle Lascombe
Stephane Bernardini
Sylvie Fauconnet
P304
P356
10.3892/OR_00000380
P577
2009-06-01T00:00:00Z